nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—Hyperbilirubinaemia—Topotecan—cervical cancer	0.0345	0.0456	CcSEcCtD
Olmesartan—Blood bilirubin increased—Topotecan—cervical cancer	0.0332	0.0438	CcSEcCtD
Olmesartan—Bone pain—Topotecan—cervical cancer	0.0328	0.0433	CcSEcCtD
Olmesartan—SLCO1B3—vagina—cervical cancer	0.0271	0.111	CbGeAlD
Olmesartan—AGTR1—epithelium—cervical cancer	0.0245	0.101	CbGeAlD
Olmesartan—AGTR1—uterine cervix—cervical cancer	0.0243	0.0998	CbGeAlD
Olmesartan—Lethargy—Topotecan—cervical cancer	0.0232	0.0307	CcSEcCtD
Olmesartan—AGTR1—decidua—cervical cancer	0.0231	0.0951	CbGeAlD
Olmesartan—AGTR1—renal system—cervical cancer	0.0227	0.0934	CbGeAlD
Olmesartan—SLCO1B1—renal system—cervical cancer	0.0216	0.089	CbGeAlD
Olmesartan—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0205	0.0271	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Topotecan—cervical cancer	0.0201	0.0265	CcSEcCtD
Olmesartan—Pancytopenia—Topotecan—cervical cancer	0.0187	0.0247	CcSEcCtD
Olmesartan—Neutropenia—Topotecan—cervical cancer	0.0184	0.0243	CcSEcCtD
Olmesartan—AGTR1—female reproductive system—cervical cancer	0.0182	0.0748	CbGeAlD
Olmesartan—Pneumonia—Topotecan—cervical cancer	0.0177	0.0233	CcSEcCtD
Olmesartan—Infestation NOS—Topotecan—cervical cancer	0.0176	0.0232	CcSEcCtD
Olmesartan—Infestation—Topotecan—cervical cancer	0.0176	0.0232	CcSEcCtD
Olmesartan—SLCO1B1—female reproductive system—cervical cancer	0.0173	0.0713	CbGeAlD
Olmesartan—AGTR1—vagina—cervical cancer	0.0164	0.0676	CbGeAlD
Olmesartan—ABCC2—renal system—cervical cancer	0.0164	0.0675	CbGeAlD
Olmesartan—Rhinitis—Topotecan—cervical cancer	0.0158	0.0209	CcSEcCtD
Olmesartan—Pharyngitis—Topotecan—cervical cancer	0.0156	0.0207	CcSEcCtD
Olmesartan—Angiopathy—Topotecan—cervical cancer	0.0143	0.0189	CcSEcCtD
Olmesartan—Mediastinal disorder—Topotecan—cervical cancer	0.0142	0.0188	CcSEcCtD
Olmesartan—Alopecia—Topotecan—cervical cancer	0.0139	0.0184	CcSEcCtD
Olmesartan—Malnutrition—Topotecan—cervical cancer	0.0137	0.0181	CcSEcCtD
Olmesartan—Back pain—Topotecan—cervical cancer	0.0133	0.0175	CcSEcCtD
Olmesartan—Muscle spasms—Topotecan—cervical cancer	0.0132	0.0174	CcSEcCtD
Olmesartan—ABCC2—female reproductive system—cervical cancer	0.0131	0.0541	CbGeAlD
Olmesartan—Ill-defined disorder—Topotecan—cervical cancer	0.0127	0.0168	CcSEcCtD
Olmesartan—Anaemia—Topotecan—cervical cancer	0.0127	0.0168	CcSEcCtD
Olmesartan—Angioedema—Topotecan—cervical cancer	0.0125	0.0166	CcSEcCtD
Olmesartan—Malaise—Topotecan—cervical cancer	0.0124	0.0163	CcSEcCtD
Olmesartan—Leukopenia—Topotecan—cervical cancer	0.0123	0.0162	CcSEcCtD
Olmesartan—Cough—Topotecan—cervical cancer	0.012	0.0158	CcSEcCtD
Olmesartan—Arthralgia—Topotecan—cervical cancer	0.0117	0.0154	CcSEcCtD
Olmesartan—Myalgia—Topotecan—cervical cancer	0.0117	0.0154	CcSEcCtD
Olmesartan—Chest pain—Topotecan—cervical cancer	0.0117	0.0154	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.0116	0.0153	CcSEcCtD
Olmesartan—Discomfort—Topotecan—cervical cancer	0.0115	0.0152	CcSEcCtD
Olmesartan—Anaphylactic shock—Topotecan—cervical cancer	0.0112	0.0148	CcSEcCtD
Olmesartan—Infection—Topotecan—cervical cancer	0.0111	0.0147	CcSEcCtD
Olmesartan—Nervous system disorder—Topotecan—cervical cancer	0.011	0.0145	CcSEcCtD
Olmesartan—Thrombocytopenia—Topotecan—cervical cancer	0.011	0.0145	CcSEcCtD
Olmesartan—Skin disorder—Topotecan—cervical cancer	0.0109	0.0144	CcSEcCtD
Olmesartan—Hyperhidrosis—Topotecan—cervical cancer	0.0108	0.0143	CcSEcCtD
Olmesartan—Anorexia—Topotecan—cervical cancer	0.0107	0.0141	CcSEcCtD
Olmesartan—AGTR1—lymph node—cervical cancer	0.0106	0.0437	CbGeAlD
Olmesartan—Musculoskeletal discomfort—Topotecan—cervical cancer	0.0102	0.0135	CcSEcCtD
Olmesartan—Dyspepsia—Topotecan—cervical cancer	0.00986	0.013	CcSEcCtD
Olmesartan—Decreased appetite—Topotecan—cervical cancer	0.00973	0.0129	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Topotecan—cervical cancer	0.00967	0.0128	CcSEcCtD
Olmesartan—Fatigue—Topotecan—cervical cancer	0.00965	0.0128	CcSEcCtD
Olmesartan—Pain—Topotecan—cervical cancer	0.00958	0.0127	CcSEcCtD
Olmesartan—Constipation—Topotecan—cervical cancer	0.00958	0.0127	CcSEcCtD
Olmesartan—Feeling abnormal—Topotecan—cervical cancer	0.00923	0.0122	CcSEcCtD
Olmesartan—Gastrointestinal pain—Topotecan—cervical cancer	0.00916	0.0121	CcSEcCtD
Olmesartan—Urticaria—Topotecan—cervical cancer	0.0089	0.0118	CcSEcCtD
Olmesartan—Body temperature increased—Topotecan—cervical cancer	0.00885	0.0117	CcSEcCtD
Olmesartan—Abdominal pain—Topotecan—cervical cancer	0.00885	0.0117	CcSEcCtD
Olmesartan—Asthenia—Topotecan—cervical cancer	0.00803	0.0106	CcSEcCtD
Olmesartan—Pruritus—Topotecan—cervical cancer	0.00792	0.0105	CcSEcCtD
Olmesartan—ABCC2—lymph node—cervical cancer	0.00769	0.0316	CbGeAlD
Olmesartan—Diarrhoea—Topotecan—cervical cancer	0.00766	0.0101	CcSEcCtD
Olmesartan—Dizziness—Topotecan—cervical cancer	0.0074	0.00978	CcSEcCtD
Olmesartan—Vomiting—Topotecan—cervical cancer	0.00712	0.00941	CcSEcCtD
Olmesartan—Rash—Topotecan—cervical cancer	0.00706	0.00933	CcSEcCtD
Olmesartan—Dermatitis—Topotecan—cervical cancer	0.00705	0.00932	CcSEcCtD
Olmesartan—Headache—Topotecan—cervical cancer	0.00701	0.00927	CcSEcCtD
Olmesartan—Nausea—Topotecan—cervical cancer	0.00665	0.00879	CcSEcCtD
